Aventura raises $14M Series C from Safeguard Scientifics and Merck GHIF


Aventura secured $14 million Series A in a round co-led by Safeguard Scientifics and Merck Global Health Innovation Fund (Merck GHI).Existing investors Excel Venture Management, HLM Venture Partners, and Memorial Care Innovation Fund also participated in the round. The company, which offers healthcare workflow optimization software, will use money to expand sales and marketing, business development, and customer support, as well as accelerate product development.

U.S.-based hospitals are estimated to spend $1.3 billion to optimize workflow for patient data access.Despite significant investments in health information systems, efficiency, data security, and workflow optimization, challenges around day-to-day access to patient data persist. The hunting-and-pecking amongst various applications in order to compile a complete view of the patient’s chart requires further investment to leverage the EMR spend. U.S.-based hospitals are estimated to spend $1.3 billion to optimize workflow for patient data access, and fewer than half of U.S. hospitals have implemented an optimization solution.

Through a patented process it calls “awareness computing,” Aventura’s workflow optimization platform delivers awareness of a user’s identity and role, their location within a facility, what device they are working on, and what patient they are treating.

“Awareness computing is the next generation in workflow optimization as it combines the security and speed benefits of SSO (Single Sign-On) with deep intelligence to deliver clinical and business awareness to the point of care,” said John Gobron, CEO of Aventura. “This round of funding along with the addition of Safeguard and Merck as strategic investors, will allow us to accelerate the rate at which we can apply innovation to address the clinical, business, and regulatory needs of healthcare providers.”